Are you Dr. McArthur?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
685 W Baltimore St
RM 480
Baltimore, MD 21201Phone+1 409-939-6867Fax+1 410-706-5103
Summary
- Dr. Monica McArthur, MD is a pediatric infectious disease specialist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland. She is affiliated with University of Maryland Medical Center and is an Instructor,Pediatrics at University of Maryland School of Medicine.
Education & Training
- University of MarylandFellowship, Pediatric Infectious Diseases, 2009 - 2012
- University of Texas Medical Branch HospitalsResidency, Pediatrics, 2006 - 2009
- University of Texas Medical Branch School of MedicineClass of 2006
Certifications & Licensure
- MD State Medical License 2009 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controll...Meagan E Deming, Elizabeth R Brown, Monica A McArthur, Stephanie J Schrag, Melissa Arvay
The Lancet. Microbe. 2025-01-27 - Role of circulating T follicular helper subsets following Ty21a immunization and oral challenge with wild type. Typhi in humans.Jayaum S Booth, Rekha R Rapaka, Monica A McArthur, Stephanie Fresnay, Thomas C Darton
Frontiers in Immunology. 2024-01-01 - 233 citationsEfficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.Lisa M Dunkle, Karen L Kotloff, Cynthia L Gay, Germán Áñez, Jeffrey M Adelglass
The New England Journal of Medicine. 2022-02-10
Press Mentions
- UMB Begins Final Stage of Novavax COVID-19 Vaccine TrialJanuary 6th, 2021
- People from Underrepresented Groups Needed to Take Part in COVID-19 Trials; Researchers Stress Safety Is Top PriorityNovember 18th, 2020
- Researchers to Test Zika Vaccine in HumansAugust 4th, 2016
- Join now to see all
Grant Support
- Molecular Basis Of Yellow Fever Virus ViscerotropismNational Institute Of Allergy And Infectious Diseases2003–2004